related documents MIR-22 SERUM A NEW NON INVASIVE PROGNOSTIC MARKER IN PATIENTS AFFECTED BY DIFFUSE LARGE B CELL LYMPHOMA: PRELIMINARY RESULTS OF A PROSPECTIVE STUDY Conferences
